ALS-I-41
ALS-I-41 is a novel, potent and selective oxytocin receptor antagonist with the potential to modulate biological activities related to social behavior and mental disorders. ALS-I-41 is being evaluated for behavioral pharmacology experiments in non-human primates and can be administered via intranasal or intramuscular injection. The central nervous system penetration and metabolic rate of ALS-I-41 were studied by mass spectrometry analysis in cerebrospinal fluid and plasma of macaque monkeys[1].
Product Specifications
CAS Number
[1369357-99-2]
UNSPSC
12352005
Target
Oxytocin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/als-i-41.html
Smiles
O=C1N(C2CCN(CC2)C(CC3=CC=C(C=C3OCCF)OC4CCN(S(=O)(C)=O)CC4)=O)C5=C(CC1)C=CC=C5
Molecular Formula
C30H38FN3O6S
Molecular Weight
587.70
References & Citations
[1]An evaluation of central penetration from a peripherally administered oxytocin receptor selective antagonist in nonhuman primates
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-117637/ALS-I-41-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-117637/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
